Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The CAnadian REgistry for Pulmonary Fibrosis (CARE-PF): Design and rationale of a national pulmonary fibrosis registry.
Ryerson CJ, Tan B, Fell CD, Manganas H, Shapera S, Mittoo S, Sadatsafavi M, To T, Gershon A, Fisher JH, Johannson KA, Hambly N, Khalil N, Marras TK, Morisset J, Wilcox PG, Halayko AJ, Khan MA, Kolb M. Ryerson CJ, et al. Among authors: sadatsafavi m. Can Respir J. 2015 Nov 2:17206. Online ahead of print. Can Respir J. 2015. PMID: 26523546 No abstract available.
Progression from Asthma to Chronic Obstructive Pulmonary Disease. Is Air Pollution a Risk Factor?
To T, Zhu J, Larsen K, Simatovic J, Feldman L, Ryckman K, Gershon A, Lougheed MD, Licskai C, Chen H, Villeneuve PJ, Crighton E, Su Y, Sadatsafavi M, Williams D, Carlsten C; Canadian Respiratory Research Network. To T, et al. Among authors: sadatsafavi m. Am J Respir Crit Care Med. 2016 Aug 15;194(4):429-38. doi: 10.1164/rccm.201510-1932OC. Am J Respir Crit Care Med. 2016. PMID: 26950751
The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry.
Ryerson CJ, Tan B, Fell CD, Manganas H, Shapera S, Mittoo S, Sadatsafavi M, To T, Gershon A, Fisher JH, Johannson KA, Hambly N, Khalil N, Marras TK, Morisset J, Wilcox PG, Halayko AJ, Khan MA, Kolb M. Ryerson CJ, et al. Among authors: sadatsafavi m. Can Respir J. 2016;2016:3562923. doi: 10.1155/2016/3562923. Epub 2016 Apr 5. Can Respir J. 2016. PMID: 27445528 Free PMC article.
Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
To T, Zhu J, Carlsten C, Larsen K, Ryckman K, Feldman LY, Crighton E, Lougheed MD, Licskai C, Villeneuve PJ, Su Y, Sadatsafavi M, Gershon A; Canadian Respiratory Research Network. To T, et al. Among authors: sadatsafavi m. Eur Respir J. 2017 Sep 11;50(3):1700644. doi: 10.1183/13993003.00644-2017. Print 2017 Sep. Eur Respir J. 2017. PMID: 28893870 Free article. No abstract available.
Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease.
Algamdi M, Sadatsafavi M, Fisher JH, Morisset J, Johannson KA, Fell CD, Kolb M, Manganas H, Cox G, Gershon AS, Halayko AJ, Hambly N, Khalil N, Shapera S, To T, Wilcox PG, Guler S, Ryerson CJ. Algamdi M, et al. Among authors: sadatsafavi m. Chest. 2019 Nov;156(5):887-895. doi: 10.1016/j.chest.2019.04.016. Epub 2019 Apr 30. Chest. 2019. PMID: 31051170 Free article.
Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
Fisher JH, Kolb M, Algamdi M, Morisset J, Johannson KA, Shapera S, Wilcox P, To T, Sadatsafavi M, Manganas H, Khalil N, Hambly N, Halayko AJ, Gershon AS, Fell CD, Cox G, Ryerson CJ. Fisher JH, et al. Among authors: sadatsafavi m. BMC Pulm Med. 2019 Nov 27;19(1):223. doi: 10.1186/s12890-019-0986-4. BMC Pulm Med. 2019. PMID: 31771541 Free PMC article.
Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease-associated Interstitial Lung Disease.
Algamdi M, Sadatsafavi M, Fisher JH, Morisset J, Johannson KA, Fell CD, Kolb M, Manganas H, Cox G, Gershon AS, Halayko AJ, Hambly N, Khalil N, Shapera S, To T, Wilcox PG, Guler S, Ryerson CJ. Algamdi M, et al. Among authors: sadatsafavi m. Ann Am Thorac Soc. 2020 Sep;17(9):1077-1084. doi: 10.1513/AnnalsATS.201911-822OC. Ann Am Thorac Soc. 2020. PMID: 32437249
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
Wong AW, Lee TY, Johannson KA, Assayag D, Morisset J, Fell CD, Fisher JH, Shapera S, Gershon AS, Cox G, Halayko AJ, Hambly N, Manganas H, Sadatsafavi M, Wilcox PG, To T, Marcoux V, Khalil N, Kolb M, Ryerson CJ. Wong AW, et al. Among authors: sadatsafavi m. Respir Res. 2020 Dec 7;21(1):322. doi: 10.1186/s12931-020-01579-7. Respir Res. 2020. PMID: 33287805 Free PMC article.
Treatment Initiation in Patients with Interstitial Lung Disease in Canada.
Assayag D, Garlick K, Johannson KA, Fell CD, Kolb M, Cox G, Hambly N, Manganas H, Morisset J, Fisher JH, Shapera S, Gershon AS, To T, Sadatsafavi M, Wilcox PG, Halayko AJ, Khalil N, Ryerson CJ. Assayag D, et al. Among authors: sadatsafavi m. Ann Am Thorac Soc. 2021 Oct;18(10):1661-1668. doi: 10.1513/AnnalsATS.202009-1122OC. Ann Am Thorac Soc. 2021. PMID: 33493425
Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung Disease.
Johannson KA, Lethebe BC, Assayag D, Fisher JH, Kolb M, Morisset J, Shapera S, Gershon AS, Hambly N, Khalil N, To T, Fell CD, Cox G, Manganas H, Halayko AJ, Marcoux V, Sadatsafavi M, Wilcox PG, Bertazzon S, Ryerson CJ. Johannson KA, et al. Among authors: sadatsafavi m. Ann Am Thorac Soc. 2022 Jan;19(1):20-27. doi: 10.1513/AnnalsATS.202102-216OC. Ann Am Thorac Soc. 2022. PMID: 34033739
296 results